期刊文献+

粘细菌STXZ54的分离鉴定及其抗肿瘤活性 被引量:7

Isolation and identification of Myxobacteria strain STXZ54 with antitumor activities
原文传递
导出
摘要 【目的】从广东省土样中分离并鉴定获得粘细菌,以丰富资源微生物库,并对其进行抗肿瘤活性的初步研究,为寻找新的抗肿瘤药物及其开发应用奠定基础。【方法】用灭活大肠杆菌诱导法,从广东土样中分离得到粘细菌,通过菌落形态观察、扫描电镜、生理生化特征、以及16s rRNA基因序列同源性分析,鉴定并归类细菌。测定不同生长时期代谢产物的抗肿瘤活性,分离纯化次级代谢产物得到抗肿瘤活性组分,测定抗肿瘤活性组分抗肿瘤谱及其对应的半致死浓度。利用激光共聚焦显微镜观察抗肿瘤活性组分作用B16后的亚细胞结构变化。【结果】分离并鉴定了粘细菌STXZ54新菌株,命名为Myxococcus macrosporus STXZ54,该粘细菌产生的抗肿瘤活性代谢产物能够较好地抑制B16、Hela、HCT-116、4T1、Hep-3B等多种肿瘤细胞,初步分离其代谢产物得到活性组分SGF5。经MTT实验算出SGF5对B16、Hela、Hep-3B、4T1细胞的IC50均在10μg/mL左右,对HCT-116细胞的IC50是70μg/mL。利用激光共聚焦显微镜观察到活性组分SGF5作用B16后亚细胞结构出现了明显的变化,结合细胞坏死与凋亡的检测初步判断SGF5能引起B16细胞的凋亡。【结论】从土样中分离得到粘细菌STXZ54,对分离到的活性组分进行了细胞毒性试验,证实其具有较好的抗肿瘤活性,有开发成抗肿瘤药物的潜在价值。 [ Objective] We isolated Myxobacteria strains from soil samples collected from Guangzhou, identified the strain and studied the antitumor activity. [ Methods ] We isolated Myxobacteria strains from soil samples through inactivated E. coli inducing method, identified the strain according to morphological observation, physiological and biochemical characteristics, and the homologous analysis of 16S rRNA sequences of nucleotides. The antitumor spectrum and the corresponding IC50 of the active component separated from the culture was analyzed. Confocal laser scanning microscope was used to examine the growth inhibitory effect of the active component on B16 cells. [ Results ] We isolated a Myxobacteria strain and identified as Myxococcus macrosporus STXZ54. The active component termed SGF5 showed cytostatic activity against B16, Hela, 4T1, Hep-3B with ICsovalues of 10 ug/mL, and HCT-116 cell with IC50 values of 70ug/mL. Subcellular structure of B16 cells were abnormal observed by confocal laser scanning microscope. Combining the apoptosis and necrosis assay result it is likely that SGF5 can induce apoptosis of B16 cells. [ Conclusion] The active component separated from the culture of Myxococcus macrosporus STXZ54 has a significant antitumor activity tested by cytotoxicity assay, which was worth exploiting as potential antitumor drugs.
出处 《微生物学报》 CAS CSCD 北大核心 2014年第5期532-542,共11页 Acta Microbiologica Sinica
基金 国家“973项目”(2012CB722301) 国家“863计划”(2011AA10A203) 国家自然科学基金(31070006) 湖南省高校科技成果产业化培育项目基金(10CY013)~~
关键词 粘细菌 分离鉴定 抗肿瘤 myxobacteria, isolation, antitumor
  • 相关文献

参考文献28

  • 1Brenner D, Krieg N, Staley J. The Proteobacteria (Part C ) : the Alpha-, Beta-, Delta-, and Epsilon proteobacteria. Garrity GM. Bergey' s Manual of Systematic Bacteriology, 2005 : 1059-1144.
  • 2Shimkets L J, Dworkin M, Reichenbach H. The myxobacteria // Dworkin M. The Prokaryotes. 3^rd eds. Berlin : Springer, 2006:31-115.
  • 3Nan B, Zusman DR. Uncovering the mystery of gliding motility in the myxobacteria. Annual Review of Genetics, 2011, 45: 21.
  • 4Volz C, Kegler C, Mtiller R. Enhancer binding proteins act as Hetero-oligomers and link secondary metabolite production to myxococcal development, motility and predation. Chemistry & Biology, 2012, 19 ( 11 ) : 1447- 1459.
  • 5Zusman DR, Scott AE, Yang Z, Kirby JR. Chemosensory pathways, motility and development in Myxococcus xanthus. Nature Reviews Microbiology, 2007, 5 ( 11 ) : 862 -872.
  • 6Mtiller FD, Schink CW, Hoiczyk E, Cserti E, Higgs PI. Spore formation in Myxococcus xanthus is tied to cytoskeleton functions and polysaccharide spore coat deposition. Molecular Microbiology, 2012, 83 (3) : 486- 505.
  • 7Spr tier C, Reichenbach H, Stackebrandt E. The correlation between morphological and phylogenetic classification of myxobacteria. International Journal of Systematic Bacteriology, 1999, 49 (3) : 1255-1262.
  • 8Iizuka T, Jojima Y, Hayakawa A, Fujii T, Yamanaka S, Fudou R. Pseudenhygromyxa salsuginis gen. nov. , sp. nov. , a myxobacterium isolated from an estuarine marsh. International Journal of Systematic and Evolutionary Microbiology, 2013, 63 ( Pt 4) : 1360-1369.
  • 9Garcia RO, Reichenbach H, Ring MW, MUller R. Phaselicystis flava gen. nov. , sp. nov. , an arachidonic acid-containing soil myxobacterium, and the description of Phaselicystidaceae fam. nov. International Journal of Systematic and Evolutionary Microbiology, 2009, 59 (6) : 1524-1530.
  • 10Herrmann J, Elnakady YA, Wiedmann RM, Ullrich A, Rohde M, Kazmaier U, Vollmar AM, Mtiller R. Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy. PLoS One, 2012, 7 (5) : e37416.

二级参考文献25

  • 1Dawid W. Biology and global distribution of Myxobacteria in soils [J]. FEMS Microbiol Rev,2000,24(4) :403-427.
  • 2Reichenbach H,Dworkin M. The Myxobacteria[M]//The prokaryotes. 2 nd ed. Albert B,New York:Spriger-Verlag , 1992:418-3487.
  • 3Behal V. Alternative sources of biologically active substances [J]. Folia Microbiol (Praha), 2003,48 (5): 563-571.
  • 4Gerth K. Myxobacteria:proficient producers of novel natural products with various biological activiyies-past and future biotechnological aspects with the focus on the genus Sorangium[J]. J Biotechnol, 2003,106 (23): 233-253.
  • 5Reichenbach H. Myxobacteria, producers of novel bloat-tire substances [J]. J Ind Microbiol Biotechnol, 2001,27 (3) :149-156.
  • 6Couch J A, Isolation of DNA from plant high polyphenolie [J]. Plant Molecular Biology Reporter, 1990,8 : 8-12.
  • 7鄂征.细胞培养与分子细胞学技术[M].北京:北京出版社,1995.
  • 8Thompson JD, Gibson TJ, Plewniak E et al. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res, 1997, 25: 4876-4882.
  • 9Saitou N, Nei M. The Neighbor-joining Method: A New Method for Reconstructing Phylogenetic Trees. Mol Biol Evol, 1987, 4: 406-425.
  • 10Kumar S, Tamura K, Nei M. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Briefings in Bioinformatics, 2004, 5: 150-163.

共引文献17

同被引文献97

  • 1周小玲,沈微,饶志明,王正祥,诸葛健.一种快速提取真菌染色体DNA的方法[J].微生物学通报,2004,31(4):89-92. 被引量:96
  • 2曹理想,周世宁.植物内生放线菌研究[J].微生物学通报,2004,31(4):93-96. 被引量:49
  • 3Kaiser D, Warrick H. Myxococcus xanthus swarms are driven by growth and regulated by a pacemaker. Journal of Bacteriology, 2011, 193(21 ) : 5898-5904.
  • 4Gerth K, Mailer R. Moderately thermophilic Myxobacteria: novel potential for the production of natural products isolation and characterization. Environmental Microbiology, 2005,7 (6) : 874- 880.
  • 5Ringel S, Greenough R, Roemer S, et al. Ambrutiein (W7783), a new antifungal antibiotie. The Journal of Amibioties, 1977, 30(5) : 371.
  • 6Reichenbaeh H, Hfle G. Biologically active secondary metabolites from myxobacteria. Biotechnology Advances, 1993, 11(2) : 219-277.
  • 7Nan B, Zusman D R. Uncovering the mystery of gliding motility in the myxobacteria. Annual Review of Genetics, 2011,45: 21.
  • 8Schmitz A, Kehrans S, Schaberle T F, et al. CoraUorazines from the Myxobacterium CoraUococcus coralloides. Journal of Natural Products, 2014.
  • 9Zhang L, An R, Wang J, et al. Exploring novel bioactive compounds from marine microbes. Current Opinion in Microbiology, 2005, 8(3): 276-281.
  • 10Gerth K, Steinmetz H, H0fle G, et al. Chlorotonil A, a Macrolide with a Unique gem - Dichloro - 1, 3 - dione Functionality from Sorangium cellulosum, So ce1525.Angewandte Chemie International Edition, 2008, 47 (3): 600- 602.

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部